Cannell Thomas R
Insider CIK 1637822 · OREX EVP, Chief Commercial Officer · SESN President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SESN Sesen Bio, Inc. | S Sale | 2023-03-02 | 2023-03-06 | 278,564 | $0.59 | $164.4K | 672,386 | SEC↗ |
| SESN Sesen Bio, Inc. | S Sale | 2023-03-02 | 2023-03-06 | 208,923 | $0.59 | $123.3K | 344,150 | SEC↗ |
| SESN Sesen Bio, Inc. | M Exercise | 2023-03-02 | 2023-03-06 | 606,800 | $0.59 | $358.0K | 950,950 | SEC↗ |
| SESN Sesen Bio, Inc. | S Sale | 2023-02-21 | 2023-02-23 | 53,727 | $0.59 | $31.7K | 553,073 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award | 2022-02-18 | 2022-02-23 | 606,800 | — | $0 | 606,800 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2021-02-19 | 2021-02-23 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2020-02-13 | 2020-02-18 | 1,450,000 | — | $0 | 1,450,000 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2019-02-21 | 2019-02-25 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2018-08-07 | 2018-08-09 | 1,350,000 | — | $0 | 1,350,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-10-13 | 2017-10-17 | 91,200 | — | $0 | 91,200 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2017-05-31 | 2017-06-02 | 2,119 | $1.55 | $3.3K | 3,882 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-02-03 | 2017-02-07 | 144,000 | — | $0 | 144,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-02-03 | 2017-02-07 | 72,000 | — | $0 | 144,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2016-11-30 | 2016-12-02 | 291 | $1.67 | $486 | 1,763 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 31,500 | — | $0 | 31,500 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 157,500 | — | $0 | 157,500 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 52,500 | — | $0 | 52,500 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 262,500 | — | $0 | 262,500 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2016-05-31 | 2016-06-02 | 9,632 | $0.34 | $3.3K | 14,723 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-02-02 | 2016-02-04 | 390,000 | — | $0 | 390,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-02-02 | 2016-02-04 | 350,000 | — | $0 | 350,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2015-11-30 | 2016-02-04 | 5,091 | $2.03 | $10.3K | 5,091 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2015-03-30 | 2015-03-31 | 425,000 | — | $0 | 425,000 | SEC↗ |